Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( (HK:6821) ) has provided an announcement.
Asymchem Laboratories (Tianjin) Co., Ltd., a Hong Kong-listed PRC joint stock company in the pharmaceutical and chemical services industry, operates through subsidiaries to deliver contract research and manufacturing solutions to drug developers. The company is led by Chairperson and CEO Dr. Hao Hong alongside a board comprising executive, non-executive, and independent non-executive directors.
The board has scheduled a meeting for 27 April 2026 to review and approve the group’s first-quarter results for the period ended 31 March 2026 and to authorize their publication. This upcoming meeting signals the imminent release of the company’s quarterly financial performance, a key event for investors and other stakeholders tracking its operational progress and market outlook.
The most recent analyst rating on (HK:6821) stock is a Buy with a HK$98.40 price target. To see the full list of analyst forecasts on Asymchem Laboratories (Tianjin) Co., Ltd. Class H stock, see the HK:6821 Stock Forecast page.
More about Asymchem Laboratories (Tianjin) Co., Ltd. Class H
Asymchem Laboratories (Tianjin) Co., Ltd. is a PRC-incorporated joint stock company listed in Hong Kong, operating in the pharmaceutical and chemical contract research and manufacturing sector. The group provides laboratory and related services through its subsidiaries, positioning itself as a key player supporting drug development and production for global clients.
Average Trading Volume: 411,778
Technical Sentiment Signal: Buy
Current Market Cap: HK$48.78B
See more insights into 6821 stock on TipRanks’ Stock Analysis page.